Pulmonx Corp. (LUNG)
2.065
-0.02
(-0.72%)
USD |
NASDAQ |
Sep 09, 13:07
Pulmonx Total Assets (Quarterly) : 114.73M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 114.73M |
| March 31, 2026 | 119.97M |
| December 31, 2025 | 133.95M |
| September 30, 2025 | 138.28M |
| June 30, 2025 | 147.19M |
| March 31, 2025 | 150.74M |
| December 31, 2024 | 167.71M |
| September 30, 2024 | 167.40M |
| June 30, 2024 | 172.63M |
| March 31, 2024 | 164.58M |
| December 31, 2023 | 178.95M |
| September 30, 2023 | 185.02M |
| June 30, 2023 | 193.11M |
| March 31, 2023 | 201.27M |
| Date | Value |
|---|---|
| December 31, 2022 | 194.08M |
| September 30, 2022 | 202.20M |
| June 30, 2022 | 212.73M |
| March 31, 2022 | 222.85M |
| December 31, 2021 | 235.65M |
| September 30, 2021 | 246.82M |
| June 30, 2021 | 248.94M |
| March 31, 2021 | 255.27M |
| December 31, 2020 | 263.71M |
| September 30, 2020 | 71.24M |
| June 30, 2020 | 66.72M |
| March 31, 2020 | |
| December 31, 2019 | 53.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
| Alphatec Holdings, Inc. | 791.03M |
| AtriCure, Inc. | 676.64M |
| Baxter International, Inc. | 19.79B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 75.54M |
| Shareholders Equity (Quarterly) | 39.20M |
| Debt to Equity Ratio | 1.434 |
| Current Ratio | 4.319 |
| Net Debt Paydown Yield | 0.26% |